|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2001, Vol. 97, No. 4, pp. 911-914
HEMATOPOIESIS
Requirement of Shp-2 tyrosine phosphatase in lymphoid and
hematopoietic cell development
Cheng-Kui Qu,
Suzanne Nguyen,
Jianzhu Chen, and
Gen-Sheng Feng
From the Burnham Institute, La Jolla, CA; Department of
Biochemistry and Molecular Biology, Walther Oncology Center, Indiana
University School of Medicine, Indianapolis, IN; and Center for Cancer
Research and Department of Biology, Massachusetts Institute of
Technology, Cambridge, MA.
Shp-1 and Shp-2 are cytoplasmic phosphotyrosine
phosphatases with similar structures. Mice deficient in Shp-2 die at
midgestation with defects in mesodermal patterning, and a hypomorphic
mutation at the Shp-1 locus results in the moth-eaten
viable (mev) phenotype. Previously, a critical role of
Shp-2 in mediating erythroid/myeloid cell development was demonstrated.
By using the RAG-2-deficient blastocyst complementation, the role of
Shp-2 in lymphopoiesis has been determined. Chimeric mice generated by
injecting Shp-2 / embryonic stem cells into
Rag-2-deficient blastocysts had no detectable mature T and B cells,
serum immunoglobulin M, or even Thy-1+ and
B220+ precursor lymphocytes. Collectively, these results
suggest a positive role of Shp-2 in the development of all blood cell
lineages, in contrast to the negative effect of Shp-1 in this process.
To determine whether Shp-1 and Shp-2 interact in hematopoiesis,
Shp-2/:mev/mev double-mutant
embryos were generated and the hematopoietic cell development in the
yolk sacs was examined. More hematopoietic stem/progenitor cells were
detected in Shp-2/:mev/mev
embryos than in Shp-2/ littermates. The partial rescue
by Shp-1 deficiency of the defective hematopoiesis caused by the Shp-2
mutation suggests that Shp-1 and Shp-2 have antagonistic effects
in hematopoiesis, possibly through a bidirectional modulation of the
same signaling pathway(s).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Wang, W.-M. Yu, W. Zhang, K. R. McCrae, B. G. Neel, and C.-K. Qu
Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis
J. Biol. Chem.,
January 9, 2009;
284(2):
913 - 920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Mei Feng, Ruopeng Sun, Chengmei Zhang, Enhua Sun, Shaochun Wei, Jiaqing Wan, and Ruopeng Sun
Increased Expression of Tyrosine Phosphatase SHP2 in Experimental Pneumococcal Meningitis: Correlation With Tumor Necrosis Factor-Alpha and Cerebrospinal Fluid Pleocytosis
J Child Neurol,
March 1, 2008;
23(3):
287 - 292.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Ohnishi, H. Yuasa, S. Tanaka, H. Sawa, M. Miura, A. Matsui, H. Higashi, M. Musashi, K. Iwabuchi, M. Suzuki, et al.
Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse
PNAS,
January 22, 2008;
105(3):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ke, E. E. Zhang, K. Hagihara, D. Wu, Y. Pang, R. Klein, T. Curran, B. Ranscht, and G.-S. Feng
Deletion of Shp2 in the Brain Leads to Defective Proliferation and Differentiation in Neural Stem Cells and Early Postnatal Lethality
Mol. Cell. Biol.,
October 1, 2007;
27(19):
6706 - 6717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, E. Diaz-Flores, G. Li, Z. Wang, Z. Kang, E. Haviernikova, S. Rowe, C.-K. Qu, W. Tse, K. M. Shannon, et al.
Abnormal hematopoiesis in Gab2 mutant mice
Blood,
July 1, 2007;
110(1):
116 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Chan and G.-S. Feng
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Blood,
February 1, 2007;
109(3):
862 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, W.-M. Yu, H. Daino, H. E. Broxmeyer, B. J. Druker, and C.-K. Qu
SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl
Blood,
January 15, 2007;
109(2):
778 - 785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. V. Nguyen, Y. Ke, E. E. Zhang, and G.-S. Feng
Conditional Deletion of Shp2 Tyrosine Phosphatase in Thymocytes Suppresses Both Pre-TCR and TCR Signals
J. Immunol.,
November 1, 2006;
177(9):
5990 - 5996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-M. Yu, H. Daino, J. Chen, K. D. Bunting, and C.-K. Qu
Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 Signaling
J. Biol. Chem.,
March 3, 2006;
281(9):
5426 - 5434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Yuan, W.-M. Yu, M. Xu, and C.-K. Qu
SHP-2 Phosphatase Regulates DNA Damage-induced Apoptosis and G2/M Arrest in Catalytically Dependent and Independent Manners, Respectively
J. Biol. Chem.,
December 30, 2005;
280(52):
42701 - 42706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Salmond, G. Huyer, A. Kotsoni, L. Clements, and D. R. Alexander
The src Homology 2 Domain-Containing Tyrosine Phosphatase 2 Regulates Primary T-Dependent Immune Responses and Th Cell Differentiation
J. Immunol.,
November 15, 2005;
175(10):
6498 - 6508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Xu, Y. Yu, S. Zheng, X. Zhao, Q. Dong, Z. He, Y. Liang, Q. Lu, Y. Fang, X. Gan, et al.
Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia
Blood,
November 1, 2005;
106(9):
3142 - 3149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tartaglia, S. Martinelli, G. Cazzaniga, V. Cordeddu, I. Iavarone, M. Spinelli, C. Palmi, C. Carta, A. Pession, M. Arico, et al.
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
Blood,
July 15, 2004;
104(2):
307 - 313.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Loh, S. Vattikuti, S. Schubbert, M. G. Reynolds, E. Carlson, K. H. Lieuw, J. W. Cheng, C. M. Lee, D. Stokoe, J. M. Bonifas, et al.
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Blood,
March 15, 2004;
103(6):
2325 - 2331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Thai, L. K. Ashman, S. N. Harbour, P. M. Hogarth, and D. E. Jackson
Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc{gamma}RIIa on the platelet plasma membrane
Blood,
November 15, 2003;
102(10):
3637 - 3645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zhao, X. Fu, L. Teng, Q. Li, and Z. J. Zhao
Blocking the Function of Tyrosine Phosphatase SHP-2 by Targeting Its Src Homology 2 Domains
J. Biol. Chem.,
October 31, 2003;
278(44):
42893 - 42898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-i. Yusa and K. S. Campbell
Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2) Can Play a Direct Role in the Inhibitory Function of Killer Cell Ig-Like Receptors in Human NK Cells
J. Immunol.,
May 1, 2003;
170(9):
4539 - 4547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Asante-Appiah and B. P. Kennedy
Protein tyrosine phosphatases: the quest for negative regulators of insulin action
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E663 - E670.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-M. Yu, T. S. Hawley, R. G. Hawley, and C.-K. Qu
Role of the docking protein Gab2 in beta 1-integrin signaling pathway-mediated hematopoietic cell adhesion and migration
Blood,
April 1, 2002;
99(7):
2351 - 2359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lelievre, H. Plun-Favreau, S. Chevalier, J. Froger, C. Guillet, G. C. A. Elson, J.-F. Gauchat, and H. Gascan
Signaling Pathways Recruited by the Cardiotrophin-like Cytokine/Cytokine-like Factor-1 Composite Cytokine. SPECIFIC REQUIREMENT OF THE MEMBRANE-BOUND FORM OF CILIARY NEUROTROPHIC FACTOR RECEPTOR alpha COMPONENT
J. Biol. Chem.,
June 15, 2001;
276(25):
22476 - 22484.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
